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Abstract - HPV infection is considered to be the most important etiologic factor in cervical cancer development. In this 
retrospective study, which included the period from 2000 to 2012, the results of two molecular techniques used in the 
detection of HPV infection among women of the South Bačka District were analyzed. By using the technique of in situ hy-
bridization and the rPCR method, the proportion of high-risk HPV among women with normal cytology was determined 
to be 19.8% and 32.7%, respectively, and among women with abnormal cytology 43.1% and 61%, respectively. Among the 
analyzed women, HPV type 16 was the most prevalent, followed by HPV types 31, 51 and 18. Application of molecular 
HPV diagnosis is valuable because it increases the sensitivity of the screening test, so that the application of both tests to 
detect cervical cancer is a true prevention of malignancy.
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Abbreviations: HPV – Human papillomavirus; PCR – polymerase chain reaction; rPCR – real-time polymerase chain reac-
tion; HR-HPV – high risk human papillomavirus; LR-HPV – low risk human papillomavirus; LSIL – low-grade squamous 
intraepithelial lesion; HSIl – high-grade squamous intraepithelial lesion; CIN – cervical intraepithelial neoplasia
INTRODUCTION
Human  papillomavirus  (HPV)  infections  are  the 
most common sexually transmitted diseases in the 
world. It is estimated that approximately 75-80% of 
sexually active people throughout their lives are ex-
posed to infection by the HPV virus, the spread of 
which is not possible to prevent for the time being 
(Bosh et al., 2007).
Human papillomavirus (HPV) causes a variety 
of benign tumors and some types are associated with 
malignant disease in humans. HPV infection is con-
sidered to be the most important etiologic factor in 
cervical cancer development. The presence of HPV 
was detected in over 99% of cases of invasive cancer. 
The established virus is carcinogenic to humans and 
cervical cancer is considered a sexually transmitted 
disease (IARC, 1995).
Molecular  methods  have  enabled  the  study  of 
HPV and contributed to the development of diag-
nostic tests to confirm its presence. Hybridization 
methods were the first molecular methods for the 
detection of HPV, and have been in use since the 
1980s (Hubbard, 2003). In situ hybridization, South-52 G. KOVAČEVIĆ ET AL.
ern blot, dot blot and digene hybrid capture differ 
in terms of performance, as well as sensitivity and 
specificity. Hybridization techniques are applicable 
in many laboratories because they do not require a 
separate space or expensive equipment to run (Villa 
at al., 2006.).
In the early 1990s, the PCR (polymerase chain 
reaction)  was  introduced  and  has  been  refined 
(Kroupis et al., 2011). DNA synthesis is catalyzed by 
thermostable DNA polymerase. Group-specific con-
sensus primers MY9/MY11 and GP5 +/GP6 + am-
plify part of the L1 gene allowing the reproduction 
of different genotypes in a single reaction (van den 
Brule et al., 2002). This test is necessary for further 
determination of the HPV genotype. The disadvan-
tages of classical PCR techniques are overcome by 
rPCR that combines the classical technique with si-
multaneous PCR detection of amplified sequences 
by fluorescent technology. A large number of copies 
generated in real-time PCR reactions accumulate in 
microgram quantities that can be easily detected by 
the intensity of fluorescence emission (Molijin et al., 
2005).
The cytological screening program is the most 
widely  used  method  in  the  detection  of  cervical 
cancer.  It  is  applied  in  developed  and  developing 
countries. The introduction of HPV diagnosis tests 
increases the sensitivity of cytological screening as 
reflected in the reduction of morbidity and mortality 
from this disease (Origoni et al., 2012).
The aim of the study was to assess whether differ-
ent molecular techniques show the presence of high-
and low-risk types of HPV among women from the 
South Bačka District in the period of one decade.
MATERIALS AND METHODS
A retrospective study was conducted at the Institute 
of Public Health of Vojvodina, Center for Virology, 
over ten years, from 2000 to 2012 (between 2001 and 
2003 diagnostic methods were not carried out). The 
sample consisted of 842 women (19 to above 50 years 
old)  with  normal  and  abnormal  cytology  smears. 
Materials (endocervical swabs) for HPV diagnosis 
were sent by gynecologists from the Health Care of 
South  Bačka  District,  Department  of  Gynecology 
and  Obstetrics,  Clinical  Center  of  Vojvodina,  and 
the Department of Gynecology, Oncology Institute 
of Vojvodina.
The technique of in situ hybridization was used 
on 111 bioptic samples and 275 endocervical swabs 
obtained  from  patients.  In  situ  hybridization  was 
performed using the Rembrandt In Situ Hybridiza-
tion-Detection Kit, (Pan Path, Netherlands) for the 
detection of specific HPV types. It included a specific 
probe for the identification of HPV types 6 and 11, 
16 and 18, 31 and 33. Tissue sections and endocervi-
cal swabs were placed on original glass slides coated 
with  3-aminopropyltriethoxysilane.  The  test  was 
performed according to the manufacturer’s instruc-
tions.
Using  real-time  PCR,  487  endocervical  swabs 
were analyzed. The swabs were collected in commer-
cial transport media (Copan) and stored at -20º C 
until processed. HPV DNA isolation protocol was 
carried out according to the manufacturer’s instruc-
tions (Kit for the extraction of DNA, Sorb A, Sacace, 
Italy). In order to control the amplification of nucleic 
acid, 10 μl of internal control (ß-globin) was added 
during isolation. From the endocervical swabs, 12 
high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 
52, 56, 58, 59) were determined with a HPV High 
Risk  Typing  Real-TM”  kit  (Sacace,  Italy)  and  two 
low-risk HPV types, 6 and 11, with HPV 6/11 Real 
TM (Sacace, Italy). The process of amplification was 
performed in 45 cycles under the following condi-
tions: 15 min at 95°C, 20 s at 95°C and 60 s at 60ºC. 
The process of amplification is performed in 42 cy-
cles under the following conditions: 15 min at 95°C, 
20 s at 95°C and 60 s at 60ºC.
Statistical  analysis  was  performed  with  the  χ2 
test.
RESULTS
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by different molecular methods in women from the 
South Bačka District (Fig. 1). In situ hybridization 
and rPCR revealed that high-risk HPV were present 
in 19.8% and 32.7% of women with normal cytology, 
respectively, and in 43.1% and 61% of women with 
abnormal cytology, respectively. Diagnosis of high-
risk HPV types was statistically more frequently de-
termined by the rPCR method (χ2=6.05; p<0.05), 
while diagnosis of low-risk HPV was significantly 
more frequently determined by in situ hybridization 
(χ2=22.36; p< 0.05). Multiple HPV infections with 
HR-HPV and LR-HPV were statistically significantly 
more often observed by the rPCR method (χ2=22.72; 
p < 0,05) (Table 1).
Histological examination of biopsy and HPV di-
agnosis was performed in 111 patients. In 28 (25.2%), 
histologically analyzed biopsies were confirmed by 
the presence of low-risk lesions (L-SIL) relating to 
CIN1, genital warts and basal hyperplasia. High-risk 
lesions (H-SIL) related to CIN2, CIN3 and Ca in situ 
were found in 26 (23.4%) biopsies. Table 2 shows the 
results of histological examination in correlation to 
HPV test.
The  results  of  rPCR  and  in  situ  hybridization 
used to examine the presence of genital HPV in-
fection in different age groups are shown in Fig. 2. 
According to the results obtained by both methods, 
genital HPV infections were the most frequent in the 
women under 30 years of age. In older age groups, 
the percentage of HPV infections was lower. 
Fig.  3  shows  the  presence  of  certain  types  of 
high-risk  HPV  as  observed  by  the  rPCR  method 
Table 1. Frequency of HR-HPV and LR-HPV among women with different cytological  findings
Samples and methods
In situ hybridization tehnique rPCR method
HR-HPV LR-HPV
Multiple
infection
HR-HPV LR-HPV
Multiple
infection
Women with normal cervical 
smear
19.8% 18.3% 4.7% 32.7% 6.1% 22.4%
Women with abnormal cervical 
smear
43.1% 25.1% 7.6% 61% 3.0% 27.5%
Table 2. Results of HPV test and histopathological findings in biopsy
Histological test
Number of 
biopsy
HPV positivity HR-HPV  LR-HPV 
Multiplex infec-
tions
CIN 1 11 7 (63.6%) 5(63.6%) 1(9.0%) 3 (27.3%)
Basal hyperplasia 2 2 (100%) 2 (100%) 0 (0%) 0 (0%)
Genital warts 15 15 (100%) 5(33.3%) 6(40.0%) 4(26.6%)
CIN 2 10 8 (80%) 7(70.0%) 0 (0%) 1 (10.0%)
CIN 3 15 12 (80%) 9(60.0%) 0 (0%) 3 (20.0%)
Carcinoma in situ 1 1 (100%) 1 (100) 0 (0%) 0 (0%)
Fig. 1. Presence of genital HPV infection among women from 
the South Bačka District from 2000 to 2012 by two molecular 
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in  endocervical  swabs  obtained  from  487  women 
from the South Bačka District. The most prevalent 
type was HPV 16, found in about 79 (27.1%) HPV-
positive patients. This was followed by types HPV31 
(23.7%), HPV 18 (11.3%), HPV 51 (10.6%), HPV 58 
(7.9%) and HPV 52 (7.2%). Other tested types (HPV 
33, 59, 56, 45, 35, 39) were demonstrated in low per-
centages, i.e. less than 5%. In the group of patients 
younger  than  30  years,  the  dominant  types  were 
HPV 16, 31, 18, 51 and 58. The same distribution of 
HPV types was also found in the age group of 30-39 
years. Among women older than 40, HPV type 16 
was dominant, followed by HPV51, and HPV 58.
DISCUSSION
In our retrospective study for the period from 2000 to 
2012, the results of two molecular techniques used in 
the detection of HPV infection among women from 
the South Bačka District were analyzed. Since the asso-
ciation of HPV infection to cervical cancer and other 
cancers is well known, molecular diagnosis is justified 
in making an accurate diagnosis. Molecular methods 
for the detection of HPV infections at the Institute of 
Public Health of Vojvodina have been applied since 
1999/2000 (Milošević, 2001). The first method was 
in situ hybridization, which was used from 2000 to 
2011 to analyze 111 samples of biopsy and 275 en-
docervical  smears.  The  method  revealed  that  the 
proportion of HPV among women from the South 
Bačka District was 51% among women with normal 
cytology, and 38% among women with abnormal cy-
tology. Results found were similar to previous results 
where the same diagnostic methods revealed that in a 
sample of women from Montenegro with symptoms 
of cervicitis, HPV infection was found in 44.3% of 
the cases (Mijović et al., 2002). In the project Decena 
that was conducted during one year, the frequency of 
Fig. 2. Presence of genital HPV infection according to age
Fig.  3.  Presence  of  certain  HPV  genotypes  proven  by  rPCR 
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HPV infection was established to be 16% by Hybrid 
Capture methods (Rajović et al., 2007). A number of 
hybridization techniques cited in the literature differ 
in sensitivity and specificity (Hubbard, 2003; Kelesi-
dis et al., 2011; Villa et al., 2006). Many authors have 
pointed out that the method of in situ hybridization 
can confirm the presence of specific HPV genotypes. 
It enables visual inspection of the cells and determines 
the localization of infection. This method allows the 
analysis of samples fixed in paraffin (Schlecht et al., 
2011). Information on histological details in combi-
nation with HPV diagnosis can exclude unnecessary 
invasive treatments, especially in young women. The 
requirement for in situ hybridization to be positive is 
the presence of 5 000 viral genome copies per millilit-
ers (Coutlee et al., 1997).
The polymerase chain reaction (PCR) has be-
come a useful method in molecular research, and 
at the beginning of 2012 it was introduced to the 
Institute of Public Health of Vojvodina. Real-time 
PCR revealed that the proportion of HPV among 
women from the South Bačka District during a one-
year period was 59.8%. Many authors have shown 
interest in comparing the results obtained by PCR 
and hybridization (Biedermann et al., 2004; Kelesi-
tis, 2011). In situ hybridization and rPCR, respec-
tively, revealed that 19.8% and 32.7% women with 
normal cytology and 43.1% and 61% women with 
abnormal  cytology  had  HPV  infections  of  high-
risk types. A higher percentage of multiple infec-
tions in the tested groups was detected by the rPCR 
method. A significantly higher percentage of HPV-
positive cases of high risk types and multiple infec-
tions were found among patients tested by PCR. 
This was due to the ability of PCR to detect more 
HPV  genotypes  and  its  greater  sensitivity.  These 
findings support the results of most comparative 
studies, which show the greater sensitivity of PCR 
as compared to in situ hybridization (Biedermann 
et al., 2004). There are studies that show equal sen-
sitivity of these two methods in the case of severe 
intraepithelial changes such as occur in CIN2/3 and 
carcinoma (Kelesitis 2011). The results of our study 
reveal  the  higher  sensitivity  of  PCR  in  detecting 
high-risk HPV types. This is due to the availability 
of appropriate primers and fluorescent probes for 
their detection. However, the method of in situ hy-
bridization has proven to be better at detecting low-
risk HPV in benign lesions, such as genital warts, 
which have a large number of viral particles and are 
highly infectious. They are indicators of sexual pro-
miscuity (Mayeaux, 2008).
It  was  observed  that  among  women  from  the 
South Bačka District, high-risk types of HPV were 
prevalent compared to low-risk types. Genital HPV 
infection is the most common in the population of 
young women under 30 years of age. According to 
our results, the peak of HPV infection was in the ear-
ly twenties, and after that its prevalence decreases, as 
was also shown by others (Bruni et al., 2011). Simi-
lar to other populations of women from the South 
Bačka District, HPV type 16 was the most prevalent, 
followed by HPV types 31, 51, 18. The previously de-
scribed distribution of HPV genotypes was charac-
teristic for women up to the age of 40. In older age 
groups, beside HPV 16, genotypes HPV 51 and 58 
were also present at a high percentage. These data 
are similar to the results provided by the multicenter 
study for the region of Eastern Europe (WHO/ICO, 
2010). Data on the presence of high and low onco-
genic risk HPV genotypes in different age groups is 
important for the development of prevention pro-
grams for malignant tumors, as well as for vaccina-
tion programs.
CONCLUSION
Screening by the Papanicolaou method is the test of 
choice for the detection of cervical cancer in many 
countries. Application of molecular HPV diagnostics 
is valuable because it increases the sensitivity of the 
screening test. The application of both tests to detect 
cervical cancer is a great improvement in the preven-
tion of malignancy.
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